Research progress Ebola Hemorrhagic Fever vaccine

Research Progress on Ebola Hemorrhagic Fever Vaccine

Ebola hemorrhagic fever is a potent infectious disease by Ebola virus caused 90% mortality rate. Ebola virus was first isolated in 1976 by, for single-stranded negative segment, non-segmented, enveloped RNA viruses belonging to filamentous virus family. Ebola virus can be divided into five different subtypes. Vaccination is the most conventional and effective prevention and infection control me...

Ebola Hemorrhagic Fever and Marburg Hemorrhagic Fever

media coverage when outbreaks occur. The causative organisms are found in tropical Africa and the Philippines. They belong to the Filoviridae family. Clinical presentations of the viral infections they cause share many common characteristics. At least 6 Marburg virus outbreaks and 21 Ebola virus outbreaks have been documented to date (Table 1). More outbreaks have probably occurred in remote ar...

ebola hemorrhagic fever

context ebola hemorrhagic fever (ehf) is amongst severe and fatal viral hemorrhagic fevers. in february 2014, a strain of the ebola virus appeared in guinea and then in liberia, sierra leone, and mali. the aim of this study was to review the literature on ehf and discuss its routes of transmission and prevention. evidence acquisition we searched medical databases (pubmed, scopus) from july 1970...

Ebola Hemorrhagic Fever

Ebola Hemorrhagic Fever and the Current State of Vaccine Development

Current Ebola virus outbreak in West Africa already reached the total number of 1,323 including 729 deaths by July 31st. the fatality is around 55% in the southeastern area of Guinea, Sierra Leone, Liberia, and Nigeria. The number of patients with Ebola Hemorrhagic Fever (EHF) was continuously increasing even though the any effective therapeutics or vaccines has not been developed yet. The Ebol...